GB9702943D0 - Wound healing - Google Patents

Wound healing

Info

Publication number
GB9702943D0
GB9702943D0 GBGB9702943.3A GB9702943A GB9702943D0 GB 9702943 D0 GB9702943 D0 GB 9702943D0 GB 9702943 A GB9702943 A GB 9702943A GB 9702943 D0 GB9702943 D0 GB 9702943D0
Authority
GB
United Kingdom
Prior art keywords
composition
disclosed
wound healing
wounds
administering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9702943.3A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Manchester
Original Assignee
Victoria University of Manchester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Victoria University of Manchester filed Critical Victoria University of Manchester
Priority to GBGB9702943.3A priority Critical patent/GB9702943D0/en
Publication of GB9702943D0 publication Critical patent/GB9702943D0/en
Priority to HK00103783.5A priority patent/HK1025504B/en
Priority to EP98903122A priority patent/EP1009425B1/en
Priority to DK98903122T priority patent/DK1009425T3/da
Priority to PT98903122T priority patent/PT1009425E/pt
Priority to AT98903122T priority patent/ATE223228T1/de
Priority to PCT/GB1998/000316 priority patent/WO1998035695A1/en
Priority to CA2280873A priority patent/CA2280873C/en
Priority to JP53544198A priority patent/JP4307561B2/ja
Priority to AU59953/98A priority patent/AU728851B2/en
Priority to US09/367,262 priority patent/US6319907B1/en
Priority to DE69807710T priority patent/DE69807710T2/de
Priority to ES98903122T priority patent/ES2181165T3/es
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
GBGB9702943.3A 1997-02-13 1997-02-13 Wound healing Pending GB9702943D0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
GBGB9702943.3A GB9702943D0 (en) 1997-02-13 1997-02-13 Wound healing
ES98903122T ES2181165T3 (es) 1997-02-13 1998-02-13 Uso de un peptido asociado a la latencia para la preparacion de un medicamento para aumentar la curacion de heridas.
PCT/GB1998/000316 WO1998035695A1 (en) 1997-02-13 1998-02-13 Wound healing
EP98903122A EP1009425B1 (en) 1997-02-13 1998-02-13 Use of Latency Associated Peptide for the manufacture of a medicament for increasing wound healing.
DK98903122T DK1009425T3 (da) 1997-02-13 1998-02-13 Anvendelse af latens-associeret-peptid til fremstilling af et medikament til forøgelse af sårheling
PT98903122T PT1009425E (pt) 1997-02-13 1998-02-13 Cicatrizacao de feridas
AT98903122T ATE223228T1 (de) 1997-02-13 1998-02-13 Verwendung von latenz assoziierten peptiden in der herstellung eines medikaments zur verbesserung der wundheilung.
HK00103783.5A HK1025504B (en) 1997-02-13 1998-02-13 Use of latency associated peptide for the manufacture of a medicament for increasing wound healing
CA2280873A CA2280873C (en) 1997-02-13 1998-02-13 The use of latency associated peptide in wound healing
JP53544198A JP4307561B2 (ja) 1997-02-13 1998-02-13 創傷の治癒
AU59953/98A AU728851B2 (en) 1997-02-13 1998-02-13 Wound healing
US09/367,262 US6319907B1 (en) 1997-02-13 1998-02-13 Wound healing
DE69807710T DE69807710T2 (de) 1997-02-13 1998-02-13 Verwendung von Latenz Assoziierten Peptiden in der Herstellung eines Medikaments zur Verbesserung der Wundheilung.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9702943.3A GB9702943D0 (en) 1997-02-13 1997-02-13 Wound healing

Publications (1)

Publication Number Publication Date
GB9702943D0 true GB9702943D0 (en) 1997-04-02

Family

ID=10807557

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9702943.3A Pending GB9702943D0 (en) 1997-02-13 1997-02-13 Wound healing

Country Status (12)

Country Link
US (1) US6319907B1 (https=)
EP (1) EP1009425B1 (https=)
JP (1) JP4307561B2 (https=)
AT (1) ATE223228T1 (https=)
AU (1) AU728851B2 (https=)
CA (1) CA2280873C (https=)
DE (1) DE69807710T2 (https=)
DK (1) DK1009425T3 (https=)
ES (1) ES2181165T3 (https=)
GB (1) GB9702943D0 (https=)
PT (1) PT1009425E (https=)
WO (1) WO1998035695A1 (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6756060B1 (en) * 1996-09-19 2004-06-29 Usbiomaterials Corp. Anti-inflammatory and antimicrobial uses for bioactive glass compositions
US6767891B2 (en) * 2000-06-14 2004-07-27 Chanda Zaveri Peptides with wound healing activity
US20100129332A1 (en) * 2000-07-31 2010-05-27 Tamar Tennenbaum Methods and pharmaceutical compositions for healing wounds
US20060258562A1 (en) * 2000-07-31 2006-11-16 Healor Ltd. Methods and pharmaceutical compositions for healing wounds
WO2002009639A2 (en) * 2000-07-31 2002-02-07 Bar Ilan University Methods and pharmaceutical compositions for healing wounds
US20030148924A1 (en) * 2002-07-09 2003-08-07 Tamar Tennenbaum Methods and pharmaceutical compositions of healing wounds
US20040037828A1 (en) * 2002-07-09 2004-02-26 Bar-Ilan University Methods and pharmaceutical compositions for healing wounds
WO2005016254A2 (en) * 2003-07-16 2005-02-24 The Ohio State University Research Foundation Methods and reagents for treating inflammation and fibrosis
WO2005013885A2 (en) * 2003-08-07 2005-02-17 Healor Ltd. Pharmaceutical compositions and methods for accelerating wound healing
EP2462944A3 (en) * 2005-08-29 2012-09-12 HealOr Ltd. Methods and compositions for prevention and treatment of diabetic and aged skin
AU2007319811A1 (en) 2006-11-15 2008-05-22 Coda Therapeutics, Inc. Improved methods and compositions for wound healing
CN102755649A (zh) * 2007-07-30 2012-10-31 希尔洛有限公司 药物组合物及相关方法
EP2205623B1 (en) * 2007-10-29 2016-03-16 Helix Biomedix Inc. Protective skin care tetrapeptides
CA2710386A1 (en) 2007-12-21 2009-07-09 Coda Therapeutics, Inc. Improved medical devices
AU2008343840A1 (en) * 2007-12-21 2009-07-09 Coda Therapeutics, Inc. Use of anti-connexin polynucleotides, peptides or antibodies for the treatment of orthopedic conditions
EP2252690A2 (en) * 2007-12-21 2010-11-24 Coda Therapeutics, Inc. Use of anti-connexin 43 polynucleotides for the treatment of abnormal or excessive scars
US20100172217A1 (en) * 2009-01-08 2010-07-08 Von Bezold Ernst System of Methods and Apparati for Handling and Modifying Information Energy and Matter by Formative Resonance
CN102325789A (zh) * 2009-02-24 2012-01-18 希尔洛有限公司 用于治疗痤疮和其它病症的内脂素治疗药物
JP2013516500A (ja) 2010-01-11 2013-05-13 ヒールオア・リミテッド 炎症性疾患および障害を治療するための方法
US9387183B2 (en) 2011-12-28 2016-07-12 Kuwait University Method of treating diabetes-related impaired wound healing
CN107109410B (zh) 2014-08-22 2021-11-02 奥克兰联合服务有限公司 通道调节剂
US10232009B1 (en) * 2017-09-29 2019-03-19 Pro Sunfun Biotech Research And Development Co., Ltd. Peptide for promoting wound healing, its composition and method of using the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2083469T3 (es) * 1989-11-22 1996-04-16 Genentech Inc Peptido asociado a una latencia y utilizaciones del mismo.
GB9106678D0 (en) 1991-03-28 1991-05-15 Ferguson Mark W J Wound healing
AU5587094A (en) 1992-10-26 1994-05-24 Kirin Brewery Company, Limited Method for producing large latent transforming growth factor-beta complexes and large latency associated peptide
US6074840A (en) * 1994-02-18 2000-06-13 The Regents Of The University Of Michigan Recombinant production of latent TGF-beta binding protein-3 (LTBP-3)
US5972335A (en) * 1994-03-29 1999-10-26 The Victoria University Of Manchester Wound healing

Also Published As

Publication number Publication date
DK1009425T3 (da) 2002-10-14
JP2001511797A (ja) 2001-08-14
DE69807710D1 (de) 2002-10-10
JP4307561B2 (ja) 2009-08-05
US6319907B1 (en) 2001-11-20
AU728851B2 (en) 2001-01-18
CA2280873C (en) 2010-04-06
EP1009425B1 (en) 2002-09-04
EP1009425A1 (en) 2000-06-21
WO1998035695A1 (en) 1998-08-20
AU5995398A (en) 1998-09-08
ATE223228T1 (de) 2002-09-15
ES2181165T3 (es) 2003-02-16
DE69807710T2 (de) 2003-06-05
HK1025504A1 (en) 2000-11-17
PT1009425E (pt) 2002-11-29
CA2280873A1 (en) 1998-08-20

Similar Documents

Publication Publication Date Title
GB9106678D0 (en) Wound healing
GB9702943D0 (en) Wound healing
NZ518608A (en) Local prevention or amelioration of pain from surgically closed wounds
WO2001041707A3 (en) Modulation of in vivo glutamine and glycine levels in the treatment of autism
WO2001007067A3 (en) Solutions and methods for inhibition of pain, inflammation and cartilage degradation
WO2000040227A3 (en) Methods for treating conditions associated with the accumulation of excess extracellular matrix
WO2002053101A3 (en) Method for treating fibrotic diseases or other indications
WO2000051566A8 (en) Scar reduction
EP1555025A3 (en) Use of dehydroepiandrosterone analogs for the treatment of asthma
PT646012E (pt) Cura de feridas e tratamento de perturbacoes fibroticas por tgfbeta-3
AU6915396A (en) Multiple sclerosis treatment
WO2003020202A3 (en) Method for reducing hypertension and heart failure
AU4790697A (en) Therapeutic use of growth factor, and delivery device, especially for the treatment of intimal hyperplasia
GB9807298D0 (en) Medicament
MY118986A (en) Use of (alpha)-1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia
CA2156481A1 (en) 5-ht2 receptor antagonist compositions useful in treating venous conditions
SE9101840L (sv) Ny medicinsk anvaendning
MY126321A (en) Use of (alpha)-adrenoreceptor antagonists in the prevention and treatment of cancer.
AU1345000A (en) Irrigation solution and method for inhibition of pain and inflammation
CZ223199A3 (cs) Použití inhibitorů COMT nebo jejich farmaceuticky vhodných solí nebo esterů pro výrobu léčiva k prevenci diabetických vaskulárních dysfunkcí
WO2000059940A3 (en) Platelet-derived growth factor related gene and protein
WO2002067851A3 (en) Method for treating fibrotic diseases or other indications iiic
MY118982A (en) Method of reducing tissue damage associated with ischemia
WO2001039760A3 (en) Method of treating batten disease
CA2306772A1 (en) Use of c18 to c26 aliphatic alcohols for the manufacture of a medicament in the treatment of hyperproliferative skin disorders